company background image
NEL0 logo

NantHealth DB:NEL0 Stock Report

Last Price

€0.26

Market Cap

€11.5m

7D

0%

1Y

-93.6%

Updated

21 Nov, 2023

Data

Company Financials

NEL0 Stock Overview

Operates as a healthcare IT company in the United States, Canada, and the United Kingdom.

NEL0 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

NantHealth, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for NantHealth
Historical stock prices
Current Share PriceUS$0.26
52 Week HighUS$5.17
52 Week LowUS$0.20
Beta1.64
11 Month Change0%
3 Month Change0%
1 Year Change-93.60%
33 Year Change-99.06%
5 Year Change-98.24%
Change since IPO-99.86%

Recent News & Updates

Recent updates

Shareholder Returns

NEL0DE Healthcare ServicesDE Market
7D0%-3.3%-2.2%
1Y-93.6%-42.9%13.3%

Return vs Industry: NEL0 underperformed the German Healthcare Services industry which returned -10.2% over the past year.

Return vs Market: NEL0 underperformed the German Market which returned 5.9% over the past year.

Price Volatility

Is NEL0's price volatile compared to industry and market?
NEL0 volatility
NEL0 Average Weekly Movementn/a
Healthcare Services Industry Average Movement5.0%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: NEL0's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine NEL0's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010373Rao Naseemnanthealth.com

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform’s comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans, and centers for medicare and medicaid services for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks.

NantHealth, Inc. Fundamentals Summary

How do NantHealth's earnings and revenue compare to its market cap?
NEL0 fundamental statistics
Market cap€11.54m
Earnings (TTM)-€63.09m
Revenue (TTM)€62.54m

0.2x

P/S Ratio

-0.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NEL0 income statement (TTM)
RevenueUS$68.44m
Cost of RevenueUS$23.74m
Gross ProfitUS$44.69m
Other ExpensesUS$113.74m
Earnings-US$69.04m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-2.51
Gross Margin65.31%
Net Profit Margin-100.89%
Debt/Equity Ratio-111.3%

How did NEL0 perform over the long term?

See historical performance and comparison